CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | LINK WILLIAM J PHD Director | Grant or award | +2,554 | 27,103 | ||
| 2024-06-06 | Fountain Tamara Director | Grant or award | +2,554 | 31,793 | ||
| 2024-06-06 | Corley Jesse Anderson Director | Grant or award | +2,554 | 32,643 | ||
| 2024-06-06 | Tammenoms Bakker Juliet Director | Grant or award | +2,554 | 37,394 | ||
| 2024-06-06 | Andrews Julie Director | Grant or award | +2,554 | 45,912 | ||
| 2024-05-17 | Tammenoms Bakker Juliet Director | Purchase | +5,000 | $61.09 | $305K | 34,840 |
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise | +15,667 | $3.93 | $62K | 42,142 |
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise | +4,840 | $4.13 | $20K | 46,982 |
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise | +4,264 | $4.34 | $19K | 51,246 |
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) | −15,667 | 0 | ||
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) | −4,840 | 0 | ||
| 2024-05-17 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) | −4,264 | 5,416 | ||
| 2024-05-03 | Kurtz Ronald M MD President & CEO | Sale 10b5-1 | −40,000 | $60.15 | $2.4M | 764,610 |
| 2024-05-01 | Thunen Shelley B Chief Financial Officer | Option exercise 10b5-1 | +10,247 | $15.60 | $160K | 23,938 |
| 2024-05-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −9,620 | $52.68 | $507K | 14,318 |
| 2024-05-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −380 | $53.04 | $20K | 13,938 |
| 2024-05-01 | Thunen Shelley B Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 46,805 | ||
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −8,857 | $49.81 | $441K | 19,545 |
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −800 | $50.27 | $40K | 18,745 |
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −8,938 | $49.81 | $445K | 9,807 |
Page 12 of 15 · 300 trades